Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial

IMPORTANCE: Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus prevalent worldwide. There are currently no licensed vaccines or therapies. OBJECTIVE: To evaluate the safety and tolerability of an investigational CHIKV virus–like particle (VLP) vaccine in endemic regions. DESIGN, SETTING, AND P...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2020-04, Vol.323 (14), p.1369-1377
Main Authors: Chen, Grace L, Coates, Emily E, Plummer, Sarah H, Carter, Cristina A, Berkowitz, Nina, Conan-Cibotti, Michelle, Cox, Josephine H, Beck, Allison, O’Callahan, Mark, Andrews, Charla, Gordon, Ingelise J, Larkin, Brenda, Lampley, Rebecca, Kaltovich, Florence, Gall, Jason, Carlton, Kevin, Mendy, Jason, Haney, Doug, May, Jeanine, Bray, Amy, Bailer, Robert T, Dowd, Kimberly A, Brockett, Brittanie, Gordon, David, Koup, Richard A, Schwartz, Richard, Mascola, John R, Graham, Barney S, Pierson, Theodore C, Donastorg, Yeycy, Rosario, Nicolas, Pape, Jean William, Hoen, Bruno, Cabié, André, Diaz, Clemente, Ledgerwood, Julie E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!